transthyretin-mediated amyloidosis
The test, based on the protein biomarker RBP4, could enable easier, noninvasive diagnosis of the condition, which is currently confirmed via heart biopsy.
The test, based on the protein biomarker RBP4, could enable easier, noninvasive diagnosis of the condition, which is currently confirmed via heart biopsy.